Correction to: Development and Content Validation of Pruritus and Symptoms Assessment for Atopic Dermatitis (PSAAD) in Adolescents and Adults with Moderate-to-Severe AD (Dermatology and Therapy, (2021), 11, 1, (221-233), 10.1007/s13555-020-00474-9)

Rebecca Hall; Mark G. Lebwohl; Andrew G. Bushmakin; Eric L. Simpson; Melinda J. Gooderham; Andreas Wollenberg; Adam Gater; Jane R. Wells; Joseph C. Cappelleri; Ming Ann Hsu; Jocelyn Papacharalambous; Elena Peeva; Anna M. Tallman; Weidong Zhang; Linda Chen

doi:10.1007/s13555-021-00567-z

Correction to: Development and Content Validation of Pruritus and Symptoms Assessment for Atopic Dermatitis (PSAAD) in Adolescents and Adults with Moderate-to-Severe AD (Dermatology and Therapy, (2021), 11, 1, (221-233), 10.1007/s13555-020-00474-9)

Rebecca Hall, Mark G. Lebwohl, Andrew G. Bushmakin, Eric L. Simpson, Melinda J. Gooderham, Andreas Wollenberg, Adam Gater, Jane R. Wells, Joseph C. Cappelleri, Ming Ann Hsu, Jocelyn Papacharalambous, Elena Peeva, Anna M. Tallman, Weidong Zhang, Linda Chen

Dermatology

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The authors would like to publish an erratum to the above article. The Discussion section of the original publication previously said: Furthermore, PSAAD was developed tomeet regulatory guidance and —unlike POEM, Itch Numeric Rating Scale (v2.0), Skin Pain Numeric Rating Scale (v2.0b), and Peak Pruritus Numerical Rating Scale— to be included in product-labelling claims in the USA and Europe.

Original language	English (US)
Pages (from-to)	1449-1450
Number of pages	2
Journal	Dermatology and Therapy
Volume	11
Issue number	4
DOIs	https://doi.org/10.1007/s13555-021-00567-z
State	Published - Aug 2021

ASJC Scopus subject areas

Dermatology

Access to Document

10.1007/s13555-021-00567-z

Fingerprint

Dive into the research topics of 'Correction to: Development and Content Validation of Pruritus and Symptoms Assessment for Atopic Dermatitis (PSAAD) in Adolescents and Adults with Moderate-to-Severe AD (Dermatology and Therapy, (2021), 11, 1, (221-233), 10.1007/s13555-020-00474-9)'. Together they form a unique fingerprint.

Cite this

Hall, R., Lebwohl, M. G., Bushmakin, A. G., Simpson, E. L., Gooderham, M. J., Wollenberg, A., Gater, A., Wells, J. R., Cappelleri, J. C., Hsu, M. A., Papacharalambous, J., Peeva, E., Tallman, A. M., Zhang, W., & Chen, L. (2021). Correction to: Development and Content Validation of Pruritus and Symptoms Assessment for Atopic Dermatitis (PSAAD) in Adolescents and Adults with Moderate-to-Severe AD (Dermatology and Therapy, (2021), 11, 1, (221-233), 10.1007/s13555-020-00474-9). Dermatology and Therapy, 11(4), 1449-1450. https://doi.org/10.1007/s13555-021-00567-z

Correction to : Development and Content Validation of Pruritus and Symptoms Assessment for Atopic Dermatitis (PSAAD) in Adolescents and Adults with Moderate-to-Severe AD (Dermatology and Therapy, (2021), 11, 1, (221-233), 10.1007/s13555-020-00474-9). / Hall, Rebecca; Lebwohl, Mark G.; Bushmakin, Andrew G. et al.

In: Dermatology and Therapy, Vol. 11, No. 4, 08.2021, p. 1449-1450.

Research output: Contribution to journal › Comment/debate › peer-review

Hall, R, Lebwohl, MG, Bushmakin, AG, Simpson, EL, Gooderham, MJ, Wollenberg, A, Gater, A, Wells, JR, Cappelleri, JC, Hsu, MA, Papacharalambous, J, Peeva, E, Tallman, AM, Zhang, W & Chen, L 2021, 'Correction to: Development and Content Validation of Pruritus and Symptoms Assessment for Atopic Dermatitis (PSAAD) in Adolescents and Adults with Moderate-to-Severe AD (Dermatology and Therapy, (2021), 11, 1, (221-233), 10.1007/s13555-020-00474-9)', Dermatology and Therapy, vol. 11, no. 4, pp. 1449-1450. https://doi.org/10.1007/s13555-021-00567-z

Hall R, Lebwohl MG, Bushmakin AG, Simpson EL, Gooderham MJ, Wollenberg A et al. Correction to: Development and Content Validation of Pruritus and Symptoms Assessment for Atopic Dermatitis (PSAAD) in Adolescents and Adults with Moderate-to-Severe AD (Dermatology and Therapy, (2021), 11, 1, (221-233), 10.1007/s13555-020-00474-9). Dermatology and Therapy. 2021 Aug;11(4):1449-1450. doi: 10.1007/s13555-021-00567-z

Hall, Rebecca ; Lebwohl, Mark G. ; Bushmakin, Andrew G. et al. / Correction to : Development and Content Validation of Pruritus and Symptoms Assessment for Atopic Dermatitis (PSAAD) in Adolescents and Adults with Moderate-to-Severe AD (Dermatology and Therapy, (2021), 11, 1, (221-233), 10.1007/s13555-020-00474-9). In: Dermatology and Therapy. 2021 ; Vol. 11, No. 4. pp. 1449-1450.

@article{41349562bf1d4dc3b75ebbb55fcd77b4,

title = "Correction to: Development and Content Validation of Pruritus and Symptoms Assessment for Atopic Dermatitis (PSAAD) in Adolescents and Adults with Moderate-to-Severe AD (Dermatology and Therapy, (2021), 11, 1, (221-233), 10.1007/s13555-020-00474-9)",

abstract = "The authors would like to publish an erratum to the above article. The Discussion section of the original publication previously said: Furthermore, PSAAD was developed tomeet regulatory guidance and —unlike POEM, Itch Numeric Rating Scale (v2.0), Skin Pain Numeric Rating Scale (v2.0b), and Peak Pruritus Numerical Rating Scale— to be included in product-labelling claims in the USA and Europe.",

author = "Rebecca Hall and Lebwohl, {Mark G.} and Bushmakin, {Andrew G.} and Simpson, {Eric L.} and Gooderham, {Melinda J.} and Andreas Wollenberg and Adam Gater and Wells, {Jane R.} and Cappelleri, {Joseph C.} and Hsu, {Ming Ann} and Jocelyn Papacharalambous and Elena Peeva and Tallman, {Anna M.} and Weidong Zhang and Linda Chen",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2021",

year = "2021",

month = aug,

doi = "10.1007/s13555-021-00567-z",

language = "English (US)",

volume = "11",

pages = "1449--1450",

journal = "Dermatology and Therapy",

issn = "2190-9172",

publisher = "Springer Verlag",

number = "4",

}

TY - JOUR

T1 - Correction to

T2 - Development and Content Validation of Pruritus and Symptoms Assessment for Atopic Dermatitis (PSAAD) in Adolescents and Adults with Moderate-to-Severe AD (Dermatology and Therapy, (2021), 11, 1, (221-233), 10.1007/s13555-020-00474-9)

AU - Hall, Rebecca

AU - Lebwohl, Mark G.

AU - Bushmakin, Andrew G.

AU - Simpson, Eric L.

AU - Gooderham, Melinda J.

AU - Wollenberg, Andreas

AU - Gater, Adam

AU - Wells, Jane R.

AU - Cappelleri, Joseph C.

AU - Hsu, Ming Ann

AU - Papacharalambous, Jocelyn

AU - Peeva, Elena

AU - Tallman, Anna M.

AU - Zhang, Weidong

AU - Chen, Linda

PY - 2021/8

Y1 - 2021/8

N2 - The authors would like to publish an erratum to the above article. The Discussion section of the original publication previously said: Furthermore, PSAAD was developed tomeet regulatory guidance and —unlike POEM, Itch Numeric Rating Scale (v2.0), Skin Pain Numeric Rating Scale (v2.0b), and Peak Pruritus Numerical Rating Scale— to be included in product-labelling claims in the USA and Europe.

AB - The authors would like to publish an erratum to the above article. The Discussion section of the original publication previously said: Furthermore, PSAAD was developed tomeet regulatory guidance and —unlike POEM, Itch Numeric Rating Scale (v2.0), Skin Pain Numeric Rating Scale (v2.0b), and Peak Pruritus Numerical Rating Scale— to be included in product-labelling claims in the USA and Europe.

UR - http://www.scopus.com/inward/record.url?scp=85111940132&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85111940132&partnerID=8YFLogxK

U2 - 10.1007/s13555-021-00567-z

DO - 10.1007/s13555-021-00567-z

M3 - Comment/debate

AN - SCOPUS:85111940132

SN - 2190-9172

VL - 11

SP - 1449

EP - 1450

JO - Dermatology and Therapy

JF - Dermatology and Therapy

IS - 4

ER -

Correction to: Development and Content Validation of Pruritus and Symptoms Assessment for Atopic Dermatitis (PSAAD) in Adolescents and Adults with Moderate-to-Severe AD (Dermatology and Therapy, (2021), 11, 1, (221-233), 10.1007/s13555-020-00474-9)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this